NCT06957691 2026-03-09
Fezo-ADT
Brigham and Women's Hospital
Phase 2 Recruiting
Clinical Trials
6 trialsNCT05071729 2025-07-14
A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally
Bayer
Phase 1 Completed
NCT06219902 2024-05-08
A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women
Bayer
Phase 1 Completed
NCT05481528 2023-05-09
A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants
Bayer
Phase 1 Completed
NCT05351892 2022-07-19
A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants
Bayer
Phase 1 Completed
NCT05061563 2022-03-17
A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults
Bayer
Phase 1 Completed